Search Medical Condition
Please enter condition
Please choose location from dropdown

Clermont-Ferrand CEDEX, France Clinical Trials

A listing of Clermont-Ferrand CEDEX, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (369) clinical trials

Postoperative and Opioid Free Anesthesia

Since the 1960's, intraoperative administration of opioids is considered a keystone of anesthesia as well as hypnotics and muscle relaxants. Synthetic opioids were introduced to achieve hemodynamic stability during anesthesia. They allow an inhibition of the sympathetic system without cardiovascular collapse and histamine release. Since then, anesthesia has changed from ...

Phase

0.0 miles

Learn More »

Treatment of Patients With Early Septic Shock and Bio-Adrenomedullin(ADM) Concentration > 70 pg/ml With ADRECIZUMAB

This is a double-blind, placebo-controlled, randomized, multicenter proof of concept and dose-finding phase II study using two doses of ADRECIZUMAB in patients with early septic shock and a bio-ADM plasma concentration at admission of > 70 pg/ml. "Early" septic shock is defined as a life-threatening organ dysfunction due to dysregulated ...

Phase

0.0 miles

Learn More »

REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.

Patients with unprovoked venous thromboembolism (VTE) or VTE associated with persistent risk factors have a high risk of recurrence after stopping anticoagulation. In the "PADIS-PE" trial comparing an additional 18 months of warfarin (target international normalized ratio (INR) from 2 to 3) versus placebo in 371 patients who have completed ...

Phase

0.0 miles

Learn More »

Psychiatric Future of Young Patients Hospitalized in the Pass'Aje Service Between 2006 and 2010

Former young psychiatric patients hospitalized in the Pass'Aje units are contacted by phone several years later to determine their psychiatric outcome.

Phase N/A

0.0 miles

Learn More »

Validation of a Screening Test for Sarcopenia in Older People

A cross-sectional multicentre study will be performed in hospital and retirement houses on patients ages 75 years old or more.

Phase N/A

0.0 miles

Learn More »

Anesthesia Management in Endovascular Therapy for Ischemic Stroke

Since 2015, the management of anterior acute ischemic stroke (AIS) involves endovascular treatment with mechanical thrombectomy (MT). This urgent, difficult and uncomfortable procedure in frail patients requires multidisciplinary care ideally involving neurologists, interventional neuroradiologists and anesthesiologists. Two anesthetic strategies are currently used: pharmacologic sedation in spontaneous ventilation or general anesthesia ...

Phase N/A

0.0 miles

Learn More »

Estimation of Vascularization After Treatment of Deep Rectovaginal Endometriosis Node by Rectal Shaving

Investigators are going to inject, at the end of a rectal shaving, a bolus of 0,2mg/kg of indocyanine green after dilution (2,5mg/ml). With de SPIES system (KARL STORZ GmbH & Co. KG, Tuttlingen, Germany), the vascularisation would be imediately fluorescent. Investigators are going to estimate the vascularization of the rectal ...

Phase

0.0 miles

Learn More »

Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.

Investigational Medicinal Products (IMPs) will be trastuzumab and pertuzumab, carboplatin, and docetaxel, as well as all endocrine therapy drugs to be administered according to HR status (hormone receptor). For cohort C, trastuzumab SC (subcutaneous) and pertuzumab IV will be IMPs until a maximum of 18 cycles. Patients will be randomly ...

Phase

0.0 miles

Learn More »

Allogeneic Hematopoietic Stem Cell Transplantation

Primary criterion - Hematological reconstitution and chimerism post-transplantation Secondary criteria - Adverse effects, graft-related mortality at D90 and at 12 months, incidence and severity of acute and/or chronic GVH reactions - Analysis of variations in post-transplantation immunological function profiles - Median duration of response in therapy-responsive patients and median duration ...

Phase

0.0 miles

Learn More »

Citrulline Allo. Evaluation of Citrullinemia as a Marker of Bowel Damage After Allogeneic Bone Marrow Transplantation in Children

30 children included. Dosage of citrullinemia on day -7, day 0 and every week up to 100 days after BMT. Histological examination and extensive infectious screening in case of persistent digestive symptoms (more than 3 days). Two groups of patients regarding on digestive involvement. Comparison of the values of citrullinemia ...

Phase N/A

0.0 miles

Learn More »